ZA200206252B - Method and compositions for treating an inflammatory disease. - Google Patents
Method and compositions for treating an inflammatory disease.Info
- Publication number
- ZA200206252B ZA200206252B ZA200206252A ZA200206252A ZA200206252B ZA 200206252 B ZA200206252 B ZA 200206252B ZA 200206252 A ZA200206252 A ZA 200206252A ZA 200206252 A ZA200206252 A ZA 200206252A ZA 200206252 B ZA200206252 B ZA 200206252B
- Authority
- ZA
- South Africa
- Prior art keywords
- compositions
- treating
- inflammatory disease
- inflammatory
- disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18087900P | 2000-02-08 | 2000-02-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200206252B true ZA200206252B (en) | 2003-08-26 |
Family
ID=22662062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200206252A ZA200206252B (en) | 2000-02-08 | 2002-08-06 | Method and compositions for treating an inflammatory disease. |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1253919A4 (ko) |
JP (1) | JP2003522142A (ko) |
KR (1) | KR20020073577A (ko) |
CN (1) | CN1398181A (ko) |
AU (1) | AU7205701A (ko) |
BR (1) | BR0108087A (ko) |
CA (1) | CA2398184A1 (ko) |
CZ (1) | CZ20022682A3 (ko) |
HK (1) | HK1051319A1 (ko) |
HU (1) | HUP0300689A3 (ko) |
IL (1) | IL150963A0 (ko) |
MX (1) | MXPA02007688A (ko) |
NO (1) | NO20023737L (ko) |
PL (1) | PL356447A1 (ko) |
WO (1) | WO2001058441A1 (ko) |
ZA (1) | ZA200206252B (ko) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7338971B2 (en) * | 2001-08-30 | 2008-03-04 | El-Naggar Mawaheb M | Treatment of inflammatory, cancer, and thrombosis disorders |
US20040242597A1 (en) * | 2001-09-19 | 2004-12-02 | Thomas Klein | Combination |
JP2005515975A (ja) * | 2001-10-31 | 2005-06-02 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | 4型ホスホジエステラーゼ阻害剤およびこれらの使用 |
WO2004098605A1 (en) * | 2003-05-12 | 2004-11-18 | Altana Pharma Ag | Pharmaceutical composition comprising a pde4 inhibitor and il-1 trap |
WO2005020926A2 (en) * | 2003-08-28 | 2005-03-10 | Pharmacia Corporation | Treatment or prevention of vascular disorders with cox-2 inhibitors in combination with cyclic amp-specific phosphodiesterase inhibitors |
CA2753604A1 (en) * | 2009-02-27 | 2010-09-02 | Boehringer Ingelheim International Gmbh | Drug combinations containing pde4-inhibitors and nsaids |
US8592400B2 (en) * | 2009-02-27 | 2013-11-26 | Boehringer Ingelheim International Gmbh | Drug combinations containing PDE4 inhibitors and NSAIDs |
ES2622519T3 (es) | 2010-07-14 | 2017-07-06 | Novartis Ag | Componentes heterocíclicos agonistas del receptor IP |
ES2565826T3 (es) | 2012-01-13 | 2016-04-07 | Novartis Ag | Pirroles fusionados como agonistas del receptor IP para el tratamiento de hipertensión arterial pulmonar (PAH) y trastornos relacionados |
US9604981B2 (en) | 2013-02-13 | 2017-03-28 | Novartis Ag | IP receptor agonist heterocyclic compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4061779A (en) * | 1973-09-11 | 1977-12-06 | Beecham Group Limited | Naphthalene derivatives having anti-inflammatory activity |
GB9108128D0 (en) * | 1991-04-15 | 1991-06-05 | Zambeletti Spa L | Novel formulation |
US5552438A (en) * | 1992-04-02 | 1996-09-03 | Smithkline Beecham Corporation | Compounds useful for treating allergic and inflammatory diseases |
US6005118A (en) * | 1996-05-03 | 1999-12-21 | Caron; Stephane | Methods of preparing 4-cyano-4 (substituted indazole) cyclohexane-carboxylic acids useful as PDE4 inhibitors |
FR2753706B1 (fr) * | 1996-09-20 | 1998-10-30 | Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant |
-
2001
- 2001-02-08 CA CA002398184A patent/CA2398184A1/en not_active Abandoned
- 2001-02-08 PL PL01356447A patent/PL356447A1/xx not_active Application Discontinuation
- 2001-02-08 AU AU72057/01A patent/AU7205701A/en not_active Abandoned
- 2001-02-08 KR KR1020027010037A patent/KR20020073577A/ko not_active Application Discontinuation
- 2001-02-08 WO PCT/US2001/003972 patent/WO2001058441A1/en not_active Application Discontinuation
- 2001-02-08 CZ CZ20022682A patent/CZ20022682A3/cs unknown
- 2001-02-08 MX MXPA02007688A patent/MXPA02007688A/es not_active Application Discontinuation
- 2001-02-08 EP EP01951123A patent/EP1253919A4/en not_active Withdrawn
- 2001-02-08 JP JP2001557552A patent/JP2003522142A/ja not_active Withdrawn
- 2001-02-08 CN CN01804708A patent/CN1398181A/zh active Pending
- 2001-02-08 BR BR0108087-3A patent/BR0108087A/pt not_active Application Discontinuation
- 2001-02-08 IL IL15096301A patent/IL150963A0/xx unknown
- 2001-02-08 HU HU0300689A patent/HUP0300689A3/hu unknown
-
2002
- 2002-08-06 ZA ZA200206252A patent/ZA200206252B/xx unknown
- 2002-08-07 NO NO20023737A patent/NO20023737L/no not_active Application Discontinuation
-
2003
- 2003-03-25 HK HK03102154.5A patent/HK1051319A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001058441A1 (en) | 2001-08-16 |
AU7205701A (en) | 2001-08-20 |
CN1398181A (zh) | 2003-02-19 |
NO20023737L (no) | 2002-09-27 |
IL150963A0 (en) | 2003-02-12 |
KR20020073577A (ko) | 2002-09-27 |
CZ20022682A3 (cs) | 2003-09-17 |
PL356447A1 (en) | 2004-06-28 |
MXPA02007688A (es) | 2002-12-13 |
NO20023737D0 (no) | 2002-08-07 |
JP2003522142A (ja) | 2003-07-22 |
BR0108087A (pt) | 2002-10-29 |
HUP0300689A2 (hu) | 2003-07-28 |
CA2398184A1 (en) | 2001-08-16 |
EP1253919A4 (en) | 2007-03-14 |
HK1051319A1 (zh) | 2003-08-01 |
EP1253919A1 (en) | 2002-11-06 |
HUP0300689A3 (en) | 2003-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001288271A1 (en) | Methods for treating inflammatory diseases | |
AU5294100A (en) | Method and compositions for treating the inflammatory response | |
ZA200106160B (en) | Compositions and methods for treating cataracts. | |
ZA200300418B (en) | Method of treating cardiovascular disease. | |
GB0016459D0 (en) | Method | |
HK1047288A1 (en) | Compositions for treating inflammatory response. | |
SG101494A1 (en) | Exposure method | |
MX246293B (es) | Composiciones y metodos para tratar hiperpigmentacion. | |
GB2370694B (en) | Implantation method | |
AU7090201A (en) | Method | |
ZA200206252B (en) | Method and compositions for treating an inflammatory disease. | |
EP1450820A4 (en) | METHOD OF TREATING AND PREVENTING INFLAMMATORY DISEASES | |
ZA200203435B (en) | Method and compositions for treating pulmonary diseases. | |
MXPA03004017A (es) | Metodo para el tratamiento de inflamacion. | |
EP1277459A4 (en) | PERMANENT SHAFT MEANS AND METHOD FOR PERMANENT SHAFT USING THIS | |
GB0005867D0 (en) | Method | |
GB0123898D0 (en) | Method for treating objects | |
GB0118883D0 (en) | Method for treating objects | |
EP1349548A4 (en) | METHOD AND COMPOSITIONS FOR TREATING PERIODONTOSIS | |
EP1261331A4 (en) | METHOD AND COMPOSITIONS FOR TREATING FIBROSANT DISEASES | |
GB0123897D0 (en) | Method for treating objects | |
GB0122810D0 (en) | Method for treating objects | |
GB0026838D0 (en) | Treatment method | |
GB0007873D0 (en) | Method | |
AU2002342188A8 (en) | Methods and compositions for treating flavivirus-mediated disease |